Edition:
United Kingdom

Navigant Consulting Inc (NCI.N)

NCI.N on New York Stock Exchange

24.30USD
7:32pm BST
Change (% chg)

$-0.03 (-0.12%)
Prev Close
$24.33
Open
$24.40
Day's High
$24.40
Day's Low
$24.03
Volume
19,559
Avg. Vol
84,835
52-wk High
$25.17
52-wk Low
$14.62

Latest Key Developments (Source: Significant Developments)

Navigant Announces Agreement With Engine Capital
Thursday, 10 May 2018 

May 10 (Reuters) - Navigant Consulting Inc ::NAVIGANT ANNOUNCES AGREEMENT WITH ENGINE CAPITAL.NAVIGANT CONSULTING INC - TARGETS RETURN OF $175 MILLION THROUGH SHARE REPURCHASE PROGRAM BY END OF 2020.NAVIGANT CONSULTING INC - BOARD HAS APPROVED AN EXPANSION OF COMPANY'S SHARE REPURCHASE AUTHORIZATION TO $175 MILLION.NAVIGANT CONSULTING INC - ENGINE CAPITAL AGREED TO WITHDRAW SLATE OF DIRECTOR NOMINEES FOR ELECTION AT 2018 ANNUAL MEETING.NAVIGANT CONSULTING INC - ENGINE CAPITAL TO VOTE FOR ALL OF NAVIGANT'S DIRECTOR NOMINEES.NAVIGANT CONSULTING INC - ENGINE CAPITAL AGREED TO WITHDRAW SLATE OF DIRECTOR NOMINEES FOR ELECTION AT 2018 ANNUAL MEETING.  Full Article

Navigant Expands Into Australia
Monday, 12 Mar 2018 

March 12 (Reuters) - Navigant Consulting Inc ::NAVIGANT EXPANDS INTO AUSTRALIA.NAVIGANT CONSULTING INC - ‍EXPANSION OF ITS GLOBAL CONSTRUCTION PRACTICE (GCP) INTO AUSTRALIA, WITH NEW OFFICES IN PERTH AND SYDNEY​.  Full Article

Navigant acquires substantially all of the assets of Quorum Consulting
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Navigant Consulting Inc :Navigant acquires substantially all of the assets of Quorum Consulting to expand its life sciences practice and overall capabilities in market access.Navigant - ‍Quorum team, including founder and CEO Kuo Bianchini Tong, will join Life Sciences practice within Navigant's Healthcare segment​.  Full Article

Navigant says Q3 earnings per share $0.25
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Navigant Consulting Inc -:Navigant reports third quarter 2017 financial results.Q3 adjusted earnings per share $0.30.Q3 earnings per share $0.25.Q3 earnings per share view $0.31 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $1.19 to $1.29.Sees FY 2017 revenue $1.04 billion to $1.065 billion.Navigant Consulting Inc - qtrly ‍total revenues $262.3 million versus $261.4 million.Q3 revenue view $241.7 million -- Thomson Reuters I/B/E/S.  Full Article

Navigant Consulting says Q3 earnings per share $0.35
Tuesday, 25 Oct 2016 

Navigant Consulting Inc : Navigant reports third quarter 2016 financial results . Navigant Consulting Inc -Q3 2016 adjusted EBITDA of $39.8 million, up 26% over Q3 2015 . Navigant Consulting Inc -Sees FY 2016 adjusted earnings per share $1.15 to $1.25 . Navigant Consulting Inc -Q3 adjusted earnings per share $0.37 . Navigant Consulting Inc -Q3 earnings per share $0.35 . Navigant Consulting Inc -Q3 revenue $261.4 million versus I/B/E/S view $233.5 million . Navigant Consulting Inc -Q3 earnings per share view $0.29 -- Thomson Reuters I/B/E/S . Navigant Consulting Inc -Raises 2016 revenue and earnings guidance . Navigant Consulting Inc - sees range for 2016 total revenues was increased to $1.00 and $1.02 billion, up from $960 million to $1.01 billion . Navigant Consulting Inc Says is currently on track to meet or exceed our expectations for full year 2016 . Navigant Consulting Inc -Sees adjusted EBITDA for full year 2016 is now expected to range between $137.5 and $145.0 million .Navigant Consulting Inc -FY2016 earnings per share view $1.15, revenue view $927.4 million -- Thomson Reuters I/B/E/S.  Full Article

Navigant acquires Dymedex Consulting to expand life sciences practice
Thursday, 1 Sep 2016 

Navigant Consulting Inc : Navigant acquires Dymedex consulting to expand its life sciences practice and overall capabilities in medical technology .Dymedex team, including Joseph Galatowitsch and Ross Meisner, will join Navigant Life Sciences practice within company's healthcare segment.  Full Article

Nemaura Medical anticipates completing clinical program and submitting PMA application around mid 2017
Thursday, 4 Aug 2016 

Nemaura Medical Inc., Completes Second Fda Pre : Submission meeting and appoints navigant to submit ide for nemaura's sugarbeat® system .Nemaura medical anticipates completing clinical program and submitting pma application around mid 2017.  Full Article

BRIEF-Navigant Announces Agreement With Engine Capital

* NAVIGANT CONSULTING INC - TARGETS RETURN OF $175 MILLION THROUGH SHARE REPURCHASE PROGRAM BY END OF 2020